Literature DB >> 18391730

In-vivo PET imaging of implanted human retinal pigment epithelium cells in a Parkinson's disease rat model.

Ruimin Wang1, Jinming Zhang, Zhe Guo, Li Shen, Aijia Shang, Yingmao Chen, Shulin Yao, Tingting He, Dayi Yin, Jiahe Tian.   

Abstract

BACKGROUND AND AIM: Researchers find that monitoring the differentiation of implanted cells in vivo is difficult. This study was designed to show that it is possible to track the efficacy of transplanted human retinal pigment epithelial cells (RPE cells) in a rat model of Parkinson's disease by using positron emission tomography (PET).
METHODS: RPE cells or normal saline were injected into striatum of the injured side of the rat model in treated and control groups, respectively. PET imaging of both groups was undertaken before transplantation and at intervals afterwards, using C-raclopride and C-beta-CFT as the markers. Observation of the rats' behaviour and immunofluorescence confocal microscopy were also used to prove the PET results.
RESULTS: PET studies showed increased accumulation of C-raclopride and decreased C-beta-CFT in the injured side of striatum in both groups. C-raclopride decreased along with a concomitant increase of C-beta-CFT after transplantation in the treated group. The changes shown by the PET studies paralleled the behavioural states and confocal microscopy observations in the treated animals.
CONCLUSION: These results suggest that even a clinical PET scanner could, to a certain extent, provide some information on the existence and in-vivo differentiation of RPE cells in a rat model of Parkinson's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18391730     DOI: 10.1097/MNM.0b013e3282f5d291

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

Review 1.  PET molecular imaging in stem cell therapy for neurological diseases.

Authors:  Jiachuan Wang; Mei Tian; Hong Zhang
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-23       Impact factor: 9.236

2.  Intrastriatal transplantation of retinal pigment epithelial cells for the treatment of Parkinson disease: in vivo longitudinal molecular imaging with 18F-P3BZA PET/CT.

Authors:  Lihong Bu; Renfei Li; Hongguang Liu; Wei Feng; Xiaoxing Xiong; Heng Zhao; Douglas Vollrath; Baozhong Shen; Zhen Cheng
Journal:  Radiology       Date:  2014-04-20       Impact factor: 11.105

3.  Pathologic findings in retinal pigment epithelial cell implantation for Parkinson disease.

Authors:  Emad S Farag; Harry V Vinters; Jeff Bronstein
Journal:  Neurology       Date:  2009-09-02       Impact factor: 9.910

4.  Transplantation of human retinal pigment epithelium cells in the treatment for Parkinson disease.

Authors:  Feng Yin; Zeng-Min Tian; Shuang Liu; Quan-Jun Zhao; Rui-Min Wang; Li Shen; Jeffery Wieman; Ying Yan
Journal:  CNS Neurosci Ther       Date:  2012-12       Impact factor: 5.243

5.  Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017).

Authors:  Hongyun Huang; Wise Young; Lin Chen; Shiqing Feng; Ziad M Al Zoubi; Hari Shanker Sharma; Hooshang Saberi; Gustavo A Moviglia; Xijing He; Dafin F Muresanu; Alok Sharma; Ali Otom; Russell J Andrews; Adeeb Al-Zoubi; Andrey S Bryukhovetskiy; Elena R Chernykh; Krystyna Domańska-Janik; Emad Jafar; W Eustace Johnson; Ying Li; Daqing Li; Zuo Luan; Gengsheng Mao; Ashok K Shetty; Dario Siniscalco; Stephen Skaper; Tiansheng Sun; Yunliang Wang; Lars Wiklund; Qun Xue; Si-Wei You; Zuncheng Zheng; Milan R Dimitrijevic; W S El Masri; Paul R Sanberg; Qunyuan Xu; Guoming Luan; Michael Chopp; Kyoung-Suok Cho; Xin-Fu Zhou; Ping Wu; Kai Liu; Hamid Mobasheri; Seiji Ohtori; Hiroyuki Tanaka; Fabin Han; Yaping Feng; Shaocheng Zhang; Yingjie Lu; Zhicheng Zhang; Yaojian Rao; Zhouping Tang; Haitao Xi; Liang Wu; Shunji Shen; Mengzhou Xue; Guanghong Xiang; Xiaoling Guo; Xiaofeng Yang; Yujun Hao; Yong Hu; Jinfeng Li; Qiang Ao; Bin Wang; Zhiwen Zhang; Ming Lu; Tong Li
Journal:  Cell Transplant       Date:  2018-02       Impact factor: 4.064

6.  Retinal pigment epithelial cells secrete neurotrophic factors and synthesize dopamine: possible contribution to therapeutic effects of RPE cell transplantation in Parkinson's disease.

Authors:  Ming Ming; Xuping Li; Xiaolan Fan; Dehua Yang; Liang Li; Sheng Chen; Qing Gu; Weidong Le
Journal:  J Transl Med       Date:  2009-06-28       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.